PALLADIO BIOSCIENCES, INC.

Profile

Company Names

PALLADIO BIOSCIENCES, INC.

Addresses

5 WALNUT GROVE DRIVE, SUITE 120, HORSHAM, PA 19044

Phone Numbers

610-256-2806

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$27,983,505.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-09-24 
$27,983,505.00 
$36,483,500.00 
$8,499,995.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANK 
 
CONDELLA 
DIRECTOR
PALLADIO BIOSCIENCES, INC.
FRANCESCO 
 
DERUBERTIS 
DIRECTOR
PALLADIO BIOSCIENCES, INC.
JOHN 
ALEXANDER 
MARTIN 
EXECUTIVE OFFICER, DIRECTOR
WORLD HEART CORP   |  PALLADIO BIOSCIENCES, INC.   |  ABCURO, INC.
MICHELE 
 
OLLIER 
DIRECTOR
NORMOXYS INC   |  AEGERION PHARMACEUTICALS, INC.   |  LINGUAFLEX, INC.   |  NORMOXYS, INC.   |  MINERVA NEUROSCIENCES, INC.   |  MEDICXI GROWTH I LP   |  DIASOME PHARMACEUTICALS, INC.   |  MEDICXI III LP   |  MEDICXI SECONDARY I LP   |  PALLADIO BIOSCIENCES, INC.
LORENZO 
 
PELLEGRINI 
EXECUTIVE OFFICER, DIRECTOR
AGILE THERAPEUTICS INC   |  BIOCRITICA, INC.   |  PALLADIO BIOSCIENCES, INC.   |  HATCH BIOFUND, LP
MARELLA 
 
THORELL 
EXECUTIVE OFFICER
REALM THERAPEUTICS PLC   |  PALLADIO BIOSCIENCES, INC.
SANFORD 
 
ZWEIFACH 
DIRECTOR
LYRIC PHARMACEUTICALS INC.   |  COMPUGEN LTD   |  PALLADIO BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#